2seventy bio, Inc. (TSVT)
May 13, 2025 - TSVT was delisted (reason: acquired by BMY)
5.00
0.00 (0.00%)
Inactive · Last trade price
on May 12, 2025
2seventy bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | 48.37 | 37.86 | 100.39 | 91.5 | 54.52 | 248.12 | Upgrade
|
| Revenue Growth (YoY) | -32.07% | -62.28% | 9.72% | 67.81% | -78.03% | 460.14% | Upgrade
|
| Cost of Revenue | 61.6 | 99.48 | 247.68 | 274.95 | 274.53 | 301.86 | Upgrade
|
| Gross Profit | -13.24 | -61.62 | -147.29 | -183.46 | -220 | -53.74 | Upgrade
|
| Selling, General & Admin | 46.11 | 43.92 | 69.41 | 79.45 | 93.51 | 90.9 | Upgrade
|
| Operating Expenses | 46.11 | 43.92 | 69.41 | 79.45 | 93.51 | 90.9 | Upgrade
|
| Operating Income | -59.35 | -105.54 | -216.7 | -262.91 | -313.51 | -144.64 | Upgrade
|
| Interest & Investment Income | 10.34 | 10.88 | 12.41 | 2.93 | 0.09 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 4.38 | 4.35 | 7.63 | 6.06 | 21.65 | 18.06 | Upgrade
|
| EBT Excluding Unusual Items | -44.63 | -90.32 | -196.67 | -253.92 | -291.77 | -126.58 | Upgrade
|
| Merger & Restructuring Charges | -8.13 | -12.3 | -8.61 | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | -12.06 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 47.99 | 42.96 | - | - | - | - | Upgrade
|
| Other Unusual Items | 0.69 | 2.42 | -0.24 | -0.23 | -0.44 | 6.47 | Upgrade
|
| Pretax Income | -4.09 | -57.25 | -217.57 | -254.15 | -292.21 | -120.11 | Upgrade
|
| Net Income | -4.09 | -57.25 | -217.57 | -254.15 | -292.21 | -120.11 | Upgrade
|
| Net Income to Common | -4.09 | -57.25 | -217.57 | -254.15 | -292.21 | -120.11 | Upgrade
|
| Shares Outstanding (Basic) | 52 | 52 | 49 | 36 | 23 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 52 | 52 | 49 | 36 | 23 | 23 | Upgrade
|
| Shares Change (YoY) | 2.02% | 5.97% | 38.27% | 51.65% | 0.56% | - | Upgrade
|
| EPS (Basic) | -0.08 | -1.10 | -4.42 | -7.13 | -12.44 | -5.14 | Upgrade
|
| EPS (Diluted) | -0.08 | -1.10 | -4.42 | -7.13 | -12.44 | -5.14 | Upgrade
|
| Free Cash Flow | -54.19 | -85.71 | -180.72 | -258.95 | -218.43 | -90.05 | Upgrade
|
| Free Cash Flow Per Share | -1.03 | -1.64 | -3.67 | -7.27 | -9.29 | -3.85 | Upgrade
|
| Gross Margin | -27.37% | -162.74% | -146.72% | -200.51% | - | -21.66% | Upgrade
|
| Operating Margin | -122.72% | -278.75% | -215.87% | -287.34% | -575.01% | -58.29% | Upgrade
|
| Profit Margin | -8.46% | -151.20% | -216.73% | -277.78% | -535.95% | -48.41% | Upgrade
|
| Free Cash Flow Margin | -112.04% | -226.36% | -180.03% | -283.02% | -400.63% | -36.29% | Upgrade
|
| EBITDA | -52.72 | -98.45 | -206.42 | -251.38 | -297.16 | -131.45 | Upgrade
|
| EBITDA Margin | -109.01% | -260.01% | -205.62% | -274.74% | - | -52.98% | Upgrade
|
| D&A For EBITDA | 6.63 | 7.1 | 10.29 | 11.53 | 16.35 | 13.19 | Upgrade
|
| EBIT | -59.35 | -105.54 | -216.7 | -262.91 | -313.51 | -144.64 | Upgrade
|
| EBIT Margin | -122.72% | -278.75% | -215.87% | -287.34% | - | -58.29% | Upgrade
|
| Revenue as Reported | 48.37 | 37.86 | 100.39 | 91.5 | 54.52 | 248.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.